CAMBRIDGE, MA / ACCESS Newswire / March 31, 2025 / Moderna, Inc. today announced that the Australian Therapeutic Goods Administration (TGA) has granted approval for mRESVIA® (mRNA-1345), an mRNA ...

Decoy Therapeutics Inc. has announced that a series of antiviral drug candidates previously designed by its Imp3act platform ...

The respiratory syncytial virus (RSV) infects cells along the human respiratory tract, from the nose to the lungs. Each year ...

The Triad's three main healthcare systems separately announced Wednesday they will lift at 7 a.m. Thursday their respiratory ...

Moderna, Inc. (NASDAQ:MRNA) today announced that the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK has granted marketing authorization for mRESVIA (mRNA-1345), indicated for ...

Shares in Moderna, Vaxcyte, Novavax and BioNTech all fell Monday after Peter Marks, head of the FDA office that reviews ...

The resignation of one of the FDA's top officials, Peter Marks, is worrying Wall Street as they await a replacement.

Just four cases of bird flu in backyard flocks have been confirmed in this area, and risk to humans is very low. Humans can't ...

Plans to add eight new conditions to the list of diseases that doctors will be required to report will come into force on 6 ...

Strongrevenueperformance,includingapproximately$1.9millionmilestoneandlicenserevenuerecognizedin2024Up to $7.5 million in grants awarded from ...

Learn more about whether Alvotech or Twist Bioscience Corporation is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.